Details for 2013730655

Up to date per 20.05.2026

Actions

Title / Product Name

BENZAMIDDERIVATE ZUR INHIBITION DER AKTIVITÄT VON ABL1, ABL2 UND BCR-ABL1

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013730655

EP Publication Number

2861576

E-Number

962259

Language

PCT Number

IB13053771

Publication Date

22.04.2015 A

10.01.2018 B1

Registration Date

10.01.2018

AT Publication Date

15.01.2018

Application Date

09.05.2013

Registration Number

Priorities

15.05.2012

201261647174 P

15.03.2013

201361789842 P

IPC

C07D 401/04 20060101AFI20131204BHEP

Maximum Duration of Protection

09.05.2033

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

FURET, PascalNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH

GROTZFELD, Robert MartinNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH

JONES, Darryl BrynleyNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH

MANLEY, PaulNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH

MARZINZIK, AndreasNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH

PELLE, Xavier Francois AndreNovartis Pharma AG, Forum 1 Novartis Campus, 4056 BaselCH

SALEM, BahaaNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH

SCHOEPFER, JosephNovartis Pharma AG, Werk Klybeck Postfach, 4002 BaselCH

JAHNKE, WolfgangNovartis Pharma AG, Postfach, 4002 BaselCH